Contact this trialFirst, we need to learn more about you.
Alpha-2 Adrenergic Agonist
LUCEMYRA for Opioid Withdrawal Syndrome
Recruiting1 awardPhase 1
Baltimore, Maryland
This trial aims to study how a medication called LUCEMYRA affects teenagers aged 12 to 18 who are stopping opioid use suddenly. The study will look at how the drug is processed in the
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service